Szulc A

Department of Psychiatry

4 papers · ORCID

ArticleKetamine

Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Early Outcomes from Poland’s First Psychiatric Drug Program B.147

Płaza O, Madejek R, Dutsch-Wicherek M +2

Europe PMC2026
ArticlePsilocybin

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.

Silczuk A, Madejek RJ, Koweszko T +4

Europe PMC2025
ArticleKetamine

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

Więdłocha M, Marcinowicz P, Komarnicki J +4

Europe PMC2024
ArticleKetamine

Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

Więdłocha M, Marcinowicz P, Komarnicki J +4

Europe PMC2024